Innova LifeSciences Corporation today announced that the Endopore Dental Implant System has been approved for sale by the State Food and Drug Administration in China.

The Endopore will be distributed by the Implant Resources Centre (Far East) Ltd. of Hong Kong, and the after sales service agent responsible for technical sales support and service will be Soft Heal Dental Equipment Ltd. of Zhongshan, Guangdong Province.

"The number of dental implant procedures in China have increased dramatically over the past few years, and with the Endopore's established presence in other major economic regions within Asia, it bodes well for the company to gain market share rapidly," stated Michael Kehoe, President and CEO of Innova. "The company, with its partners in Hong Kong and the PRC, will begin an aggressive launch campaign during the first quarter of this year."